AN OPEN-LABEL STUDY OF GV20-0251 IN PATIENTS WITH ADVANCED AND/OR REFRACTORY SOLID TUMOR MALIGNANCIES

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Advanced And/or Refractory Solid Tumor Malignancies
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Patients must have one or more metastatic solid tumors that are evaluable or measurable
    2. Disease-free of active second/secondary or prior malignancies for 2 years or longer
    3. Life expectancy of over 12 weeks

You may not be eligible for this study if the following are true:

    1. Acute leukemia or chronic lymphocytic leukemia (CLL)
    2. Active, uncontrolled bacterial, viral, or fungal infections requiring systemic therapy within 7 days of the first dose of study drug
    3. Cardiac disease, myocardial infarction within the past 6 months, or unstable arrhythmia



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.